no key · no human

Pharmexec API, RSS and sitemap

Every article Pharmexec publishes, as JSON, through an open API with no key and no signup. 134 of their articles are indexed right now, refreshed hourly.

United States#10,681 by volume

Four ways to pull pharmexec.com

All four are ours, all four are live, and none of them needs a key.

JSON Search this publisher

Every article we hold from pharmexec.com, newest first. Add q= to search inside.

curl -s "https://freenewsapi.ai/v1/search?host=www.pharmexec.com&size=20"open it →

RSS Subscribe in any reader

The same articles as an RSS 2.0 feed. Works in Feedly, Inoreader, Thunderbird — anywhere.

curl -s "https://freenewsapi.ai/v1/rss?host=www.pharmexec.com&size=50"open it →

JSON Feed For apps

JSON Feed 1.1, the same content in a format apps parse natively.

curl -s "https://freenewsapi.ai/v1/feed.json?host=www.pharmexec.com&size=50"open it →

Trimmed For agents

Only the fields an agent needs — title, url, date, language — so the response stays small.

curl -s "https://freenewsapi.ai/v1/search?host=www.pharmexec.com&size=20&fields=title,url,published_at,lang"open it →

What this outlet covers, by share of its recent output:

health 60%business 20%technology 20%

Call the API

A live request. Paste it into a terminal and Pharmexec headlines come back as JSON.

bash
curl "https://freenewsapi.ai/v1/search?host=www.pharmexec.com&size=5"
134
articles indexed
134
in the last 30 days
12
median per day
0
languages
3189 min
median crawl lag
20.08 → 04.09
archive depth

Publishing volume

Articles per day over the last 12 days. The busiest hour is 10:00 UTC — that is when the newsroom pushes its main batch.

2026-08-20: 1 articles2026-08-21: 5 articles2026-08-24: 10 articles2026-08-25: 14 articles2026-08-26: 16 articles2026-08-27: 12 articles2026-08-28: 10 articles2026-08-31: 8 articles2026-09-01: 24 articles2026-09-02: 12 articles2026-09-03: 12 articles2026-09-04: 10 articles08-2008-2408-2608-2809-0109-0309-04
bash
curl "https://freenewsapi.ai/v1/stats?host=www.pharmexec.com&top=10"

Publishing rhythm

When Pharmexec actually publishes, by hour of day (UTC) and by day of week — measured from 134 timestamps, not from a schedule they advertise.

00: 00001: 00102: 00203: 00304: 00405: 00506: 00607: 00708: 00809: 20910: 551011: 01112: 81213: 311314: 21415: 11516: 01617: 111718: 131819: 111920: 02021: 02122: 02223: 023
Mon: 18MonTue: 38TueWed: 28WedThu: 25ThuFri: 25FriSat: 0SatSun: 0Sun

Latest articles

The 18 most recent Pharmexec articles in the index — the same rows the API returns, rendered for humans.

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Zanvastro]]>
2026-09-04 17:19 UTC
<![CDATA[Ionis wins FDA approval for Zanvastro, the first disease-modifying treatment for Alexander disease, Pharmaceutical Executive’s weekly biotech roundup gathers ana
<![CDATA[FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults ]]>
2026-09-04 13:56 UTC
<![CDATA[FDA has approved Ionis Pharmaceuticals' Zanvastro (zilganersen) as the first disease-modifying treatment for Alexander disease. ]]>
<![CDATA[Your Questions Answered: The Biggest Pharma and Biotech Stories This Week]]>
2026-09-04 10:00 UTC
<![CDATA[CAR-T safety halts, a rare disease trial failure, a China licensing deal, an mRNA flu vaccine advance, and nine new MFN agreements.]]>
<![CDATA[The Limitations of JAK Inhibitors When Treating IBS]]>
2026-09-04 10:00 UTC
<![CDATA[Christian Tinel on why Rinvoq succeeds in IBD despite safety concerns — and what a cleaner oral alternative would mean for the market.]]>
<![CDATA[The Limitations of JAK Inhibitors When Treating IBD]]>
2026-09-04 10:00 UTC
<![CDATA[Christian Tinel on why Rinvoq succeeds in IBD despite safety concerns — and what a cleaner oral alternative would mean for the market.]]>
<![CDATA[What's Next for Compounded Peptides: Q&A with Nate Hill ]]>
2026-09-04 09:00 UTC
<![CDATA[Nate Hill, co-founder & CEO, Strive Pharmacy, breaks down looming questions around the completed FDA PCAC hearing on peptides. ]]>
<![CDATA[Pharmaceutical Executive Daily: Ultragenyx's Apazunersen Fails Phase III Trial]]>
2026-09-03 17:33 UTC
<![CDATA[Ultragenyx shares plunge after apazunersen fails its Phase III trial in Angelman syndrome, Mark Cziraky of Carelon Research talks through the mechanics of analyz
<![CDATA[Ultragenyx Shares Drop Following Failed Phase III Clinical Trial ]]>
2026-09-03 13:34 UTC
<![CDATA[Ultragenyx shares plunge more than 40% after apazunersen fails to meet both endpoints in a Phase III trial for Angelman syndrome. ]]>
<![CDATA[The Ron Lanton Report: What Are We Doing This All For?]]>
2026-09-03 10:00 UTC
<![CDATA[Melanie Whittington, managing director and head of the Leerink Center for Pharmacoeconomics, joins Ron Lanton to argue that biopharmaceutical policy only makes s
<![CDATA[The Mechanics of Analyzing Linked Data Sets]]>
2026-09-03 10:00 UTC
<![CDATA[Carelon Research's Mark Cziraky on why trusted research environments don't change how analysis is done — just how fast and richly it can begin.]]>
<![CDATA[How New Therapies are Tackling Unmet Needs in IBS]]>
2026-09-03 10:00 UTC
<![CDATA[Christian Tinel on why IBD's unmet need comes down to one thing: an oral therapy with biologic-like efficacy and better safety.]]>
<![CDATA[What Moments in FDA’s Review Process Should Patients and Providers be Watching Closely?]]>
2026-09-03 10:00 UTC
<![CDATA[Nate Hill, co-founder & CEO, Strive, notes the key milestone to watch for during the remaining step in FDA's formal Category one announcement for peptides. ]]>
<![CDATA[How New Therapies are Tackling Unmet Needs in IBD]]>
2026-09-03 10:00 UTC
<![CDATA[Christian Thienel on why IBD's unmet need comes down to one thing: an oral therapy with biologic-like efficacy and better safety.]]>
<![CDATA[Pharmaceutical Executive Daily: Novartis and BMS Halt CAR-T Trials]]>
2026-09-02 19:21 UTC
<![CDATA[Novartis and Bristol Myers Squibb pause autoimmune CAR-T trials over safety concerns, a dealmaking roundup covers Alteogen's licensing deal with Novartis, NewBio
<![CDATA[Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report ]]>
2026-09-02 18:50 UTC
<![CDATA[Novartis suspends eight autoimmune trials of its CAR-T therapy Rap-cel after three cases of fatal outcomes, while Bristol Myers Squibb voluntarily pauses enrollm
<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTech Partners
2026-09-02 13:31 UTC
<![CDATA[Alteogen grants Novartis options to develop subcutaneous formulations using its ALT-B4 hyaluronidase platform, NewBiologix and Synastra partner to develop a stab
<![CDATA[Redefining Medical Strategy in Obesity Through Real-World iNSIGHTS]]>
2026-09-02 10:00 UTC
<![CDATA[Real-world evidence tells you what happened. Real-World iNSIGHTS tell you why — and what to do next. A new framework for medical affairs.]]>
<![CDATA[Managing the Uncertainty of Inventory, Staffing, and Formulary Planning Around Peptides?]]>
2026-09-02 10:00 UTC
<![CDATA[Nate Hill, co-founder & CEO, Strive, explains how Strive is managing peptide uncertainty by pre-sourcing API, running stability and testing, and working with leg

Harvest it all

Page through the archive by date. from and to accept YYYY-MM-DD or relative values such as now-7d.

bash
curl "https://freenewsapi.ai/v1/search?host=www.pharmexec.com&from=now-7d&size=100"

To poll for new material, keep the timestamp of the newest article you saw and ask only for what came after it:

bash
curl "https://freenewsapi.ai/v1/search?host=www.pharmexec.com&from=now-1h&sort=date_asc"

Article bodies come with full_text=true. No key, no quota tier, no header — see the search endpoint for every parameter.

Metadata quality

How well Pharmexec marks up its own pages — useful if you are deciding whether to parse them yourself.

0%
dates from JSON-LD
0%
articles with a byline
0%
articles with sections
average page weight

Crawl lag — the delay between publication and the article reaching this index — is 3189 min at the median, 7616 minutes at the 90th percentile.

FAQ

Does Pharmexec have an official API?

Not a public one. This endpoint is the practical alternative: their articles as structured JSON, with title, lead, publication time, section, byline and a link back to the original.

How do I get their RSS feed?

Most publishers expose one at /rss or /feed, but feeds carry only the last few dozen items and drop them within hours. This index keeps 134 of their articles and lets you filter by date, language and section.

How many articles does Pharmexec publish per day?

12 on a median day, measured across 12 days.

Can I use this commercially?

The API is free and unauthenticated. What you may do with the content is between you and the publisher: we return metadata, a lead paragraph and a link, not a licence.